Prevention and Control of Porcine Epidemic Diarrhea: The Development of Recombination-Resistant Live Attenuated Vaccines

Porcine epidemic diarrhea (PED), causing up to 100% mortality in neonatal pigs, is a highly contagious enteric disease caused by PED virus (PEDV). The highly virulent genogroup 2 (G2) PEDV emerged in 2010 and has caused huge economic losses to the pork industry globally. It was first reported in the...

Full description

Bibliographic Details
Main Authors: Xiaoyu Niu, Qiuhong Wang
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/14/6/1317
_version_ 1797481351522287616
author Xiaoyu Niu
Qiuhong Wang
author_facet Xiaoyu Niu
Qiuhong Wang
author_sort Xiaoyu Niu
collection DOAJ
description Porcine epidemic diarrhea (PED), causing up to 100% mortality in neonatal pigs, is a highly contagious enteric disease caused by PED virus (PEDV). The highly virulent genogroup 2 (G2) PEDV emerged in 2010 and has caused huge economic losses to the pork industry globally. It was first reported in the US in 2013, caused country-wide outbreaks, and posed tremendous hardship for many pork producers in 2013–2014. Vaccination of pregnant sows/gilts with live attenuated vaccines (LAVs) is the most effective strategy to induce lactogenic immunity in the sows/gilts and provide a passive protection via the colostrum and milk to suckling piglets against PED. However, there are still no safe and effective vaccines available after about one decade of endeavor. One of the biggest concerns is the potential reversion to virulence of an LAV in the field. In this review, we summarize the status and the major obstacles in PEDV LAV development. We also discuss the function of the transcriptional regulatory sequences in PEDV transcription, contributing to recombination, and possible strategies to prevent the reversion of LAVs. This article provides insights into the rational design of a promising LAV without safety issues.
first_indexed 2024-03-09T22:13:19Z
format Article
id doaj.art-634d4bc6e7a646d2b164b58c0cd3bf86
institution Directory Open Access Journal
issn 1999-4915
language English
last_indexed 2024-03-09T22:13:19Z
publishDate 2022-06-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj.art-634d4bc6e7a646d2b164b58c0cd3bf862023-11-23T19:27:20ZengMDPI AGViruses1999-49152022-06-01146131710.3390/v14061317Prevention and Control of Porcine Epidemic Diarrhea: The Development of Recombination-Resistant Live Attenuated VaccinesXiaoyu Niu0Qiuhong Wang1Center for Food Animal Health, Department of Animal Sciences, College of Food, Agricultural and Environmental Sciences, The Ohio State University, Wooster, OH 44691, USACenter for Food Animal Health, Department of Animal Sciences, College of Food, Agricultural and Environmental Sciences, The Ohio State University, Wooster, OH 44691, USAPorcine epidemic diarrhea (PED), causing up to 100% mortality in neonatal pigs, is a highly contagious enteric disease caused by PED virus (PEDV). The highly virulent genogroup 2 (G2) PEDV emerged in 2010 and has caused huge economic losses to the pork industry globally. It was first reported in the US in 2013, caused country-wide outbreaks, and posed tremendous hardship for many pork producers in 2013–2014. Vaccination of pregnant sows/gilts with live attenuated vaccines (LAVs) is the most effective strategy to induce lactogenic immunity in the sows/gilts and provide a passive protection via the colostrum and milk to suckling piglets against PED. However, there are still no safe and effective vaccines available after about one decade of endeavor. One of the biggest concerns is the potential reversion to virulence of an LAV in the field. In this review, we summarize the status and the major obstacles in PEDV LAV development. We also discuss the function of the transcriptional regulatory sequences in PEDV transcription, contributing to recombination, and possible strategies to prevent the reversion of LAVs. This article provides insights into the rational design of a promising LAV without safety issues.https://www.mdpi.com/1999-4915/14/6/1317porcine epidemic diarrhea viruslive attenuated vaccinesrecombinationsafety issue
spellingShingle Xiaoyu Niu
Qiuhong Wang
Prevention and Control of Porcine Epidemic Diarrhea: The Development of Recombination-Resistant Live Attenuated Vaccines
Viruses
porcine epidemic diarrhea virus
live attenuated vaccines
recombination
safety issue
title Prevention and Control of Porcine Epidemic Diarrhea: The Development of Recombination-Resistant Live Attenuated Vaccines
title_full Prevention and Control of Porcine Epidemic Diarrhea: The Development of Recombination-Resistant Live Attenuated Vaccines
title_fullStr Prevention and Control of Porcine Epidemic Diarrhea: The Development of Recombination-Resistant Live Attenuated Vaccines
title_full_unstemmed Prevention and Control of Porcine Epidemic Diarrhea: The Development of Recombination-Resistant Live Attenuated Vaccines
title_short Prevention and Control of Porcine Epidemic Diarrhea: The Development of Recombination-Resistant Live Attenuated Vaccines
title_sort prevention and control of porcine epidemic diarrhea the development of recombination resistant live attenuated vaccines
topic porcine epidemic diarrhea virus
live attenuated vaccines
recombination
safety issue
url https://www.mdpi.com/1999-4915/14/6/1317
work_keys_str_mv AT xiaoyuniu preventionandcontrolofporcineepidemicdiarrheathedevelopmentofrecombinationresistantliveattenuatedvaccines
AT qiuhongwang preventionandcontrolofporcineepidemicdiarrheathedevelopmentofrecombinationresistantliveattenuatedvaccines